Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Vogel

Showing results (111-120 of 185) with videos related to

Pageof 19
Sort By:
Heart (British Cardiac Society)|March 21, 2025
Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary interventionFrancesca Maria Di Muro, Samantha Sartori, Birgit Vogel, et al.
Journal of the American College of Cardiology|May 18, 2019
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary InterventionPaul Guedeney, Bimmer E Claessen, Deborah N Kalkman, et al.
European Heart Journal|April 10, 2025
Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention†Benjamin Bay, Richard Tanner, Michael Gao, et al.
European Heart Journal|October 26, 2018
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventionsDeborah N Kalkman, Melissa Aquino, Bimmer E Claessen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 2, 2024
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trialSamin K Sharma, Roxana Mehran, Birgit Vogel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2020
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysisPaul Guedeney, Sabato Sorrentino, Gennaro Giustino, et al.
International Journal of Cardiology|December 5, 2020
A sex paradox in clinical outcomes following complex percutaneous coronary interventionJohny Nicolas, Bimmer E Claessen, Davide Cao, et al.
Nature Reviews. Disease Primers|June 8, 2019
ST-segment elevation myocardial infarctionBirgit Vogel, Bimmer E Claessen, Suzanne V Arnold, et al.
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
European Journal of Preventive Cardiology|March 20, 2025
Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular diseaseFrancesca Maria Di Muro, Birgit Vogel, Samantha Sartori, et al.
Pageof 19

Showing results (111-120 of 185) with videos related to

Sort By:
Pageof 19
Heart (British Cardiac Society)|March 21, 2025
Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary interventionFrancesca Maria Di Muro, Samantha Sartori, Birgit Vogel, et al.
Journal of the American College of Cardiology|May 18, 2019
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary InterventionPaul Guedeney, Bimmer E Claessen, Deborah N Kalkman, et al.
European Heart Journal|April 10, 2025
Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention†Benjamin Bay, Richard Tanner, Michael Gao, et al.
European Heart Journal|October 26, 2018
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventionsDeborah N Kalkman, Melissa Aquino, Bimmer E Claessen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 2, 2024
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trialSamin K Sharma, Roxana Mehran, Birgit Vogel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2020
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysisPaul Guedeney, Sabato Sorrentino, Gennaro Giustino, et al.
International Journal of Cardiology|December 5, 2020
A sex paradox in clinical outcomes following complex percutaneous coronary interventionJohny Nicolas, Bimmer E Claessen, Davide Cao, et al.
Nature Reviews. Disease Primers|June 8, 2019
ST-segment elevation myocardial infarctionBirgit Vogel, Bimmer E Claessen, Suzanne V Arnold, et al.
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
European Journal of Preventive Cardiology|March 20, 2025
Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular diseaseFrancesca Maria Di Muro, Birgit Vogel, Samantha Sartori, et al.
Pageof 19